Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Stage III-IVB Head and Neck Cancer

Conditions:   Head and Neck Carcinoma of Unknown Primary;   Locally Advanced Head and Neck Squamous Cell Carcinoma;   Locally Advanced Hypopharyngeal Squamous Cell Carcinoma;   Locally Advanced Laryngeal Squamous Cell Carcinoma;   Locally Advanced Oral Cavity Squamous Cell Carcinoma;   Locally Adva nced Oropharyngeal Squamous Cell Carcinoma;   Locally Advanced Sinonasal Squamous Cell Carcinoma;   Maxillary Sinus Squamous Cell Carcinoma;   Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8;   Stage III Hypopharyngeal Carcinoma AJCC v8;   Stage III Laryngeal  Cancer AJCC v8;   Stage III Lip and Oral Cavity Cancer AJCC v8;   Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8;   Stage III Sinonasal Cancer AJCC v8;   Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8;   Stage IVA Hypopharyngeal Carcinoma  AJCC v8;   Stage IVA Laryngeal Cancer AJCC v8;   Stage IVA Lip and Oral Cavity Cancer AJCC v8;   Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8;   Stage IVA Sinonasal Cancer AJCC v8;   Stage IVB Hypopharyngeal Carcinoma AJCC v8;   Stage IVB Laryngeal Cancer  AJCC v8;   Stage IVB Lip and Oral Cavity Cancer AJCC v8;   Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8;   Stage IVB Sinonasal Cancer AJCC v8 Interventions:   Drug: Cisplatin;   Drug: Ipatasertib;   Radiation: Radiation Therapy Sponsor:   Nationa...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials